VVitaNova

Capabilities

Built for the full arc of evidence — from Phase 2 through Phase 4.

II

Phase 2

Dose-finding, safety, and early efficacy. Skilled in adaptive designs, biomarker-driven enrichment, and PK/PD intensive sampling.

  • FIH-experienced PIs
  • Adaptive & basket designs
  • Intensive PK sampling rooms

III

Phase 3

Pivotal, registration-enabling trials. Built for high enrollment volume without compromising data quality.

  • Multi-arm randomized studies
  • Central & local lab workflows
  • Risk-based monitoring ready

IV

Phase 4

Post-marketing surveillance, real-world evidence, and label-expansion studies in our community population.

  • Registry & observational
  • PROs and digital endpoints
  • Long-term follow-up cohorts

Therapeutic areas

Where we go deep.

Each therapeutic area is led by a dedicated principal investigator with at least ten years of trial experience in the indication.

01

Vaccines

  • · Influenza, RSV, mRNA platforms
  • · Adult & pediatric cohorts
  • · Healthy volunteer recruitment
02

Cardiometabolic

  • · Type 2 diabetes & GLP-1s
  • · NASH / MASH biopsy studies
  • · Lipid lowering & PCSK9
03

Pulmonology

  • · COPD exacerbation prevention
  • · Severe & eosinophilic asthma
  • · IPF & chronic cough
04

Metabolic

  • · Obesity pharmacotherapy
  • · Thyroid & adrenal disorders
  • · Rare metabolic indications
05

General Medicine

  • · Acute & chronic infection
  • · Dermatology — psoriasis, AD
  • · Pain, primary care indications

On-site infrastructure

Equipped for the protocols sponsors actually run.

Imaging & cardiac

12-lead ECG, telemetry, ambulatory BP, Holter, spirometry, DLCO

Sample handling

Refrigerated & ambient centrifuges, -20°C and -80°C monitored storage

Pharmacy

Locked, temperature-controlled IP storage with 21 CFR Part 11 logging

Infusion

Two private IV infusion suites with overnight observation capability

Regulatory

Central IRB (Advarra, WCG) and local IRB submissions, 1572s in 48h

Quality

Internal QA audits every quarter, audit-ready essential documents

Need a capability we haven't listed?

We've likely done it. Send us the protocol synopsis.

Contact our operations team